참고문헌 (49)

1. Int J Immunopharmacol Bartlett 7 7 1985 10.1016/0192-0561(85)90003-7 Immunopharmacological profile of a novel isoxazol derivative, HWA 486 with potential antirheumatic activity. I. Disease modifying action on adjuvant arthritis of the rat 

   상세보기

2. Bartlett 215 1982 (HWA 486), a novel immunorestoring drug 

3. Agents Actions Popovic 19 313 1986 10.1007/BF01971235 Disease modifying activity of HWA 486 on the development of SLE in MRL/1 mice 

   상세보기

4. Agents Actions Pasternak 21 241 1987 10.1007/BF01966478 Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis 

   상세보기

5. Scand J Rheumatol Suppl Bartlett 75 290 1988 10.3109/03009748809096781 Development of autoimmunity in MRL/1pr mice and the effects of drugs on this murine disease 

   상세보기

6. Int J Immunopharmacol Thoenes 11 921 1989 10.1016/0192-0561(89)90114-8 Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats 

   상세보기

7. Agents Actions Hambleton 29 328 1990 10.1007/BF01966465 Drug actions on delayed-type hypersensitivity in rats with developing and establish adjuvant arthritis 

   상세보기

8. Clin Immunol Immunopathol Ogawa 61 103 1991 10.1016/S0090-1229(06)80011-5 Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats 

   상세보기

9. Immunopharmacology Glant 23 105 1992 10.1016/0162-3109(92)90034-A Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide 

   상세보기

10. Transplant Proc Kuchle 23 1083 1991 Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent 

    상세보기

11. Transplant Proc Williams 25 745 1993 Immunosuppressive effects of leflunomide in a cardiac allograft model 

    상세보기

12. Transplant Proc Schorlemmer 25 763 1993 Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative 

    상세보기

13. Transplantation McChesney 57 1717 1994 10.1097/00007890-199457120-00005 An evaluation of leflunomide in the canine renal transplantation model 

    상세보기

14. Invest Ophthalmol Vis Sci Niederkorn 35 3783 1994 Promotion of corneal allograft survival with leflunomide 

    상세보기

15. Transplant Proc He 26 1613 1994 Oral leflunomide prevents small bowel allograft rejection in the rat 

    상세보기

16. Transplant Proc Morris 27 445 1995 

    상세보기

17. Yuh D, Morris RE, Hoyt G, Guiterrez J, Reitz B, Robbins R. Leflunomide prolongs pulmonary allograft and xenograft survival. J Heart Lung Transplant (in press). 

18. Transplant Proc Gregory 28 945 1996 Combination leflunomide and cyclosporine immunosuppression prevents MLR mismatched allograft rejection in Mongrel dogs 

19. Transplant Proc Wright 26 1310 1994 Lefluonomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice 

20. Transplant Proc Lin 27 305 1995 Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model 

    상세보기

21. Transplantation Xiao 58 828 1994 10.1097/00007890-199410150-00014 Leflunomide controls rejection in hamster to rat cardiac xenografts 

    상세보기

22. Transplant Proc MacDonald 26 3244 1994 Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat 

    상세보기

23. J Heart Lung Transplant Gregory 13 S68 1994 Leflunomide is a new immunosuppressant that effectively reduces arterial intimal thickening produced by alloimmune injury [Abstract] 

24. J Heart Lung Transplant Morris 14 S65 1995 Use of cyclosporine (CsA), mycophenolic acdi (MPA), rapamycin (RPM), lefluonomide (LFM) or deoxyspergualin (DSG) for prevention and treatment of obliterative airway disease (OAD) in new animal models [Abstract] 

25. Transplant Proc Morris 27 2068 1995 Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogues) for the suppression of graft vascular disease and obliterative bronchiolitis 

26. Kidney Int Lin 48 23 1995 Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions 

27. Rheumatology Musikic 51 58 1992 Efficacy of leflunomide in patients with rheumatoid arthritis 

28. Cao WW, Kao PN, Chao AL, Gardner P, Ng J, Morris RE. Mechanism of the antiproliferative action of leflunomide: A771726 the active metabolite of leflunomide does not block T-cell receptor-mediated signal transduction, but its antiproliferative effects are antagonized by pyrimidine nucleosides. J Heart Lung Transplant (in press). 

29. Inflamm Res Cherwinski 44 317 1995 10.1007/BF01796261 Leflunomide interferes with pyrimidine nucleotide biosynthesis 

    상세보기

30. J Biol Chem Williamson 38 22467 1996 Dihydroorotate dehydrogenase: a high affinity binding protein for A771726 and mediator of a range of biological effects of the immunomodulatory compound 

31. FEBS Lett Mattor 334 161 1993 10.1016/0014-5793(93)81704-4 Inhibition of epidermal growth factor receptor tyrosine kinase activity by leflunomide 

    상세보기

32. Agents Actions Nikcevich 41 C279 1994 10.1007/BF01987669 Inhibition of interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide 

    상세보기

33. Xiao 203 1993 Leflunomide: a promising immunosuppressant in transplantation 

34. Agents Action Zielinski 38 C80 1993 10.1007/BF01991144 Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers 

    상세보기

35. Transplantation Chong 55 1361 1993 10.1097/00007890-199306000-00028 Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation 

    상세보기

36. Chong 1 163 1994 In vivo and in vitro immunosuppression with leflunomide 

37. Transplant Proc Steele 25 754 1993 Effects of immunosuppressive therapy on the rat aortic allograft model 

    상세보기

38. Transplant Proc Allison 25 8 1993 Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs 

    상세보기

39. Transplantation Lang 59 382 1995 10.1097/00007890-199502150-00013 Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo 

    상세보기

40. Transplantation Williams 57 1223 1994 10.1097/00007890-199404270-00015 Leflunomide in experimental transplantation: control of rejection and alloantibody production, reversal of acute rejection and interaction with cyclosporin 

    상세보기

41. 10.1007/978-3-662-00818-8_81 Lin Y, Vandeputte M, Waer M. A short term combination therapy with cyclosporine and Rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats. Transplant Int (in press). 

    

42. Transplant Proc Lin 28 977 1996 Immunosuppressants suppressing signal T of T cell activation enable cyclosporin to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats 

43. Transplant Proc Lin 28 952 1996 Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts 

    상세보기

44. J Immunol Mosier 199 1874 1977 10.4049/jimmunol.119.6.1874 The ontogeny of thymic-dependent antibody responses in vitro in normal mice and mice with an X-linked B cell defect 

    상세보기

45. J Exp Med Hawokawa 157 202 1983 10.1084/jem.157.1.202 The Ly-1B cell subpopualtion in normal, immune defective and autoimmune mice 

    상세보기

46. Science Thomas 261 355 1993 10.1126/science.8332900 Colocalization of X linked agammaglobulinemia and X-linked immunodeficiency genes 

    상세보기

47. Transplantation Swan 60 887 1995 10.1097/00007890-199510000-00025 Immunosuppressive effects of leflunomide in experimental chronic vascular rejection 

    상세보기

48. Transplantation Xiao 60 1065 1995 10.1097/00007890-199511270-00001 Pharmacologically induced regression of chronic transplant rejection 

    상세보기

49. Lin Y, Segers C, Waer M. Efficacy of the leflunomide analogue X920715 as compared to leflunomide in cardiac allo and xenograft transplantation in rats. Submitted for publication.